ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/24 | 2,702 | 2,760 | 2,606 | 2,678 | +26 | +1% | 398,700 |
2020/03/23 | 2,655 | 2,697 | 2,550 | 2,652 | +44 | +1.7% | 559,300 |
2020/03/19 | 2,573 | 2,608 | 2,477 | 2,608 | +222 | +9.3% | 512,900 |
2020/03/18 | 2,488 | 2,548 | 2,374 | 2,386 | -52 | -2.1% | 449,200 |
2020/03/17 | 2,260 | 2,480 | 2,189 | 2,438 | +152 | +6.6% | 699,000 |
2020/03/16 | 2,404 | 2,448 | 2,283 | 2,286 | -109 | -4.6% | 553,200 |
2020/03/13 | 2,409 | 2,475 | 2,264 | 2,395 | -114 | -4.5% | 550,200 |
2020/03/12 | 2,574 | 2,589 | 2,476 | 2,509 | -115 | -4.4% | 354,900 |
2020/03/11 | 2,605 | 2,675 | 2,600 | 2,624 | +56 | +2.2% | 649,300 |
2020/03/10 | 2,498 | 2,592 | 2,403 | 2,568 | +47 | +1.9% | 338,600 |
2020/03/09 | 2,566 | 2,567 | 2,490 | 2,521 | -95 | -3.6% | 234,500 |
2020/03/06 | 2,652 | 2,660 | 2,600 | 2,616 | -67 | -2.5% | 200,800 |
2020/03/05 | 2,712 | 2,712 | 2,667 | 2,683 | +43 | +1.6% | 219,800 |
2020/03/04 | 2,599 | 2,683 | 2,594 | 2,640 | +7 | +0.3% | 369,100 |
2020/03/03 | 2,674 | 2,689 | 2,617 | 2,633 | +31 | +1.2% | 508,900 |
2020/03/02 | 2,526 | 2,615 | 2,510 | 2,602 | +86 | +3.4% | 337,300 |
2020/02/28 | 2,519 | 2,542 | 2,483 | 2,516 | -63 | -2.4% | 433,700 |
2020/02/27 | 2,615 | 2,621 | 2,568 | 2,579 | -51 | -1.9% | 280,800 |
2020/02/26 | 2,626 | 2,634 | 2,603 | 2,630 | -26 | -1% | 585,100 |
2020/02/25 | 2,688 | 2,699 | 2,650 | 2,656 | -150 | -5.3% | 420,800 |
2020/02/21 | 2,796 | 2,833 | 2,792 | 2,806 | +3 | +0.1% | 231,200 |
2020/02/20 | 2,798 | 2,819 | 2,791 | 2,803 | -11 | -0.4% | 236,900 |
2020/02/19 | 2,838 | 2,845 | 2,805 | 2,814 | +3 | +0.1% | 199,900 |
2020/02/18 | 2,861 | 2,867 | 2,811 | 2,811 | -50 | -1.7% | 202,000 |
2020/02/17 | 2,913 | 2,913 | 2,854 | 2,861 | -98 | -3.3% | 299,300 |
2020/02/14 | 2,952 | 2,964 | 2,937 | 2,959 | -3 | -0.1% | 338,900 |
2020/02/13 | 2,960 | 2,991 | 2,937 | 2,962 | -123 | -4% | 279,400 |
2020/02/12 | 3,060 | 3,115 | 3,050 | 3,085 | +55 | +1.8% | 245,800 |
2020/02/10 | 2,997 | 3,040 | 2,997 | 3,030 | -55 | -1.8% | 113,200 |
2020/02/07 | 3,115 | 3,115 | 3,065 | 3,085 | -35 | -1.1% | 110,600 |
2020/02/06 | 3,050 | 3,135 | 3,040 | 3,120 | +122 | +4.1% | 250,900 |
2020/02/05 | 2,993 | 3,020 | 2,975 | 2,998 | +32 | +1.1% | 200,200 |
2020/02/04 | 2,938 | 2,976 | 2,930 | 2,966 | +2 | +0.1% | 244,400 |
2020/02/03 | 2,986 | 2,987 | 2,953 | 2,964 | -36 | -1.2% | 238,200 |
2020/01/31 | 2,998 | 3,020 | 2,997 | 3,000 | +21 | +0.7% | 220,500 |
2020/01/30 | 2,985 | 3,000 | 2,975 | 2,979 | -56 | -1.8% | 252,100 |
2020/01/29 | 3,015 | 3,040 | 3,005 | 3,035 | +20 | +0.7% | 178,300 |
2020/01/28 | 3,035 | 3,040 | 3,005 | 3,015 | -55 | -1.8% | 209,200 |
2020/01/27 | 3,095 | 3,095 | 3,060 | 3,070 | -70 | -2.2% | 142,100 |
2020/01/24 | 3,145 | 3,155 | 3,125 | 3,140 | -15 | -0.5% | 117,600 |
2020/01/23 | 3,155 | 3,165 | 3,125 | 3,155 | -5 | -0.2% | 120,900 |
2020/01/22 | 3,140 | 3,170 | 3,130 | 3,160 | +25 | +0.8% | 124,500 |
2020/01/21 | 3,160 | 3,165 | 3,130 | 3,135 | -45 | -1.4% | 115,600 |
2020/01/20 | 3,195 | 3,200 | 3,175 | 3,180 | -30 | -0.9% | 101,300 |
2020/01/17 | 3,245 | 3,250 | 3,200 | 3,210 | ±0 | ±0% | 132,200 |
2020/01/16 | 3,270 | 3,270 | 3,205 | 3,210 | ±0 | ±0% | 132,000 |
2020/01/15 | 3,205 | 3,240 | 3,200 | 3,210 | +35 | +1.1% | 195,900 |
2020/01/14 | 3,200 | 3,205 | 3,155 | 3,175 | -15 | -0.5% | 203,700 |
2020/01/10 | 3,185 | 3,210 | 3,180 | 3,190 | +30 | +0.9% | 128,400 |
2020/01/09 | 3,170 | 3,180 | 3,155 | 3,160 | +30 | +1% | 86,100 |
1251~
1300
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム